Involvement of sigma-1 receptor modulation in the antidepressant action of venlafaxineDHIR, Ashish; KULKARNI, S. K.Neuroscience letters. 2007, Vol 420, Num 3, pp 204-208, issn 0304-3940, 5 p.Article

Role of CYP2D6 in the stereoselective disposition of venlafaxine in humansEAP, Chin B; LESSARD, Etienne; BAUMANN, Pierre et al.Pharmacogenetics (London). 2003, Vol 13, Num 1, pp 39-47, issn 0960-314X, 9 p.Article

Evaluation of Efficacy of the Perioperative Administration of Venlafaxine or Gabapentin on Acute and Chronic Postmastectomy PainYASSER MOHAMED AMR; AYMAN ABD AL-MAKSOUD YOUSEF.The Clinical journal of pain. 2010, Vol 26, Num 5, pp 381-385, issn 0749-8047, 5 p.Article

Serotonin syndrome induced by low-dose venlafaxinePAN, Jan-Jhy; SHEN, Winston W.The Annals of pharmacotherapy. 2003, Vol 37, Num 2, pp 209-211, issn 1060-0280, 3 p.Article

Association analysis between the Val66Met polymorphism in the brain-derived neurotrophic factor (BDNF) gene and treatment response to venlafaxine XR in generalized anxiety disorderNARASIMHAN, Sneha; AQUINO, TiffanyD; HODGE, Rachel et al.Neuroscience letters. 2011, Vol 503, Num 3, pp 200-202, issn 0304-3940, 3 p.Article

Venlafaxine in dysthymic disorderDUNNER, D. L; HENDRICKSON, H. E; BEA, C et al.The Journal of clinical psychiatry. 1997, Vol 58, Num 12, pp 528-531, issn 0160-6689Article

Liquid chromatography-tandem mass spectrometry (LC-MS-MS) method for simultaneous determination of venlafaxine and its active metabolite O-desmethyl venlafaxine in human plasmaBHATT, Jignesh; JANGID, Arvind; VENKATESH, Gantala et al.Journal of chromatography. B. 2005, Vol 829, Num 1-2, pp 75-81, issn 1570-0232, 7 p.Article

Venlafaxine: A 2003 updateGUTIERREZ, Mary A; STIMMEL, Glen L; AISO, Janet Y et al.Clinical therapeutics. 2003, Vol 25, Num 8, pp 2138-2154, issn 0149-2918, 17 p.Article

Non-selective opioid receptor antagonism of the antidepressant-like effect of venlafaxine in the forced swimming test in miceBERROCOSO, Esther; ROJAS-CORRALES, Maria Olga; MICO, Juan Antonio et al.Neuroscience letters. 2004, Vol 363, Num 1, pp 25-28, issn 0304-3940, 4 p.Article

Concentrations of venlafaxine and its main metabolite O-desmethylvenlafaxine during pregnancyTER HORST, P. G. J; LARMENE-BELD, K. H. M; BOSMAN, J et al.Journal of clinical pharmacy and therapeutics (Print). 2014, Vol 39, Num 5, pp 541-544, issn 0269-4727, 4 p.Article

Efficacy of venlafaxine extended-release monotherapy for first-episode depression with painful physical symptomsXIAO HUANG; CHAO LI; LUO, Yan-Li et al.Neuroreport (Oxford). 2013, Vol 24, Num 7, pp 364-369, issn 0959-4965, 6 p.Article

The role of venlafaxine in the treatment of obsessive-compulsive disorderPHELPS, Nicole J; CATES, Marshall E.The Annals of pharmacotherapy. 2005, Vol 39, Num 1, pp 136-140, issn 1060-0280, 5 p.Article

Tolerability of high-dose venlafaxine in depressed patientsHARRISON, C. Louise; FERRIER, Nicol; YOUNG, Allan H et al.Journal of psychopharmacology (Oxford). 2004, Vol 18, Num 2, pp 200-204, issn 0269-8811, 5 p.Article

Pneumopathie médicamenteuse sous traitement par venlafaxine et propranolol = Drug-induced pneumonitis in a patient treated with venlafaxine and propanololPRIOU, P; GAGNADOUX, F; DEHE, C et al.Revue des maladies respiratoires. 2008, Vol 25, Num 5, pp 610-613, issn 0761-8425, 4 p.Article

Evidence for an antihyperalgesic effect of venlafaxine in vincristine-induced neuropathy in ratMARCHAND, Fabien; ALLOUI, Abdelkrim; PELISSIER, Teresa et al.Brain research. 2003, Vol 980, Num 1, pp 117-120, issn 0006-8993, 4 p.Article

Desvenlafaxine : Another Me Too Drug?SOPKO, Michael A; EHRET, Megan J; GRGAS, Marina et al.The Annals of pharmacotherapy. 2008, Vol 42, Num 10, pp 1439-1446, issn 1060-0280, 8 p.Article

Controlled comparison of two different doses of milnacipran in major depressive outpatientsKANEMOTO, Kousuke; MATSUBARA, Momoyo; YAMASHITA, Koichi et al.International clinical psychopharmacology. 2004, Vol 19, Num 6, pp 343-346, issn 0268-1315, 4 p.Article

Evaluation of efficacy of the perioperative administration of venlafaxine XR in the prevention of postmastectomy pain syndromeREUBEN, Scott S; MAKARI-JUDSON, Grace; LURIE, Shari D et al.Journal of pain and symptom management. 2004, Vol 27, Num 2, pp 133-139, issn 0885-3924, 7 p.Article

An open treatment trial of venlafaxine for elderly patients with dysthymic disorderDEVANAND, D. P; JUSZCZAK, Nicole; NOBLER, Mitchell S et al.Journal of geriatric psychiatry and neurology. 2004, Vol 17, Num 4, pp 219-224, issn 0891-9887, 6 p.Article

Difference in pre- and post-treatment plasma DHEA levels were significantly and positively correlated with difference in pre- and post- treatment hamilton depression scores following successful therapy for major depressionHSIAO, Cheng-Cheng.Psychoneuroendocrinology. 2006, Vol 31, Num 7, pp 839-846, issn 0306-4530, 8 p.Article

The antihyperalgesic effect of venlafaxine in diabetic rats does not involve the opioid systemMARCHAND, Fabien; ALLOUI, Abdelkrim; CHAPUY, Eric et al.Neuroscience letters. 2003, Vol 342, Num 1-2, pp 105-108, issn 0304-3940, 4 p.Article

Venlafaxine extended release for the treatment of patients with premature ejaculation: a pilot, single-blind, placebo-controlled, fixed-dose crossover study on short-term administration of an antidepressant drugKILIC, S; ERGIN, H; BAYDINC, Y. C et al.International journal of andrology (Print). 2005, Vol 28, Num 1, pp 47-52, issn 0105-6263, 6 p.Article

A case series of increased libido and spontaneous orgasm associated with venlafaxine treatment. Authors' replyALTINDAG, Abdurrahman; GUNES, Mehmet.Progress in neuro-psychopharmacology & biological psychiatry. 2008, Vol 32, Num 3, pp 895-896, issn 0278-5846, 2 p.Article

De nouveaux antidépresseurs sur le marché = The new antidepressant agentSCHAAD, N.Médecine et hygiène. 2001, Vol 59, Num 2372, pp 2497-2500, issn 0025-6749Article

Newer antidepressants and the discontinuation syndrome. DiscussionHADDAD, P; KAPLAN; LEJOYEUX et al.The Journal of clinical psychiatry. 1997, Vol 58, pp 17-22, issn 0160-6689, SUP7Conference Paper